Navigation Links
DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
Date:9/8/2009

ation enteritis is a serious complication for colorectal cancer patients receiving radiation therapy that impacts their quality of life and can require treatment modification," stated William Small, Jr., MD, FACRO, Professor and Vice Chairman, Department of Radiation Oncology, Associate Medical Director, Robert H. Lurie Comprehensive Cancer Center of Northwestern University and a Principal Investigator for the Phase 1/2 clinical study. "Based on oral BDP's proven pharmacology in treating severe gastrointestinal inflammation, DOR201 represents a potential prophylactic option that would enable physicians/patients to maintain planned treatment regimens to battle the underlying malignancy. I look forward to working with DOR on the continued development of DOR201."

"In addition to the FDA's clearance of our IND and its granting of fast-track designation, this grant award further validates the merits of our DOR201 clinical program," stated Christopher J. Schaber, PhD, President and CEO of DOR. "Based on its known pharmacology, we believe that oral administration of BDP may help to prevent or reduce the severity of acute radiation enteritis and the deleterious effects it has on the patient's and treating physician's ability to deal with the underlying malignancy. We look forward to working with our Medical Advisory Board and investigational sites to initiate this study."

About Acute Radiation Enteritis

Radiation enteritis is a condition in which the lining of the bowel becomes swollen and inflamed during or after radiation therapy to the abdomen, pelvis or rectum. External radiation therapy is used to treat most types of cancer, including cancers of the bladder, uterus, cervix, rectum, prostate and vagina. During delivery of treatment, some level of radiation will also be delivered to healthy tissue, including the bowel, leading to acute and chronic toxicities. The large and small bowels are very sensitive to
'/>"/>

SOURCE DOR BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Research-Based Biopharmaceutical Company Awards Trials to DATATRAK
2. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
3. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
4. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
5. CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders
6. DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
7. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
8. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
9. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
10. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
11. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014  In today,s marketplace, ... costly and challenging - as is managing a portfolio ... Is it possible - or even preferable - ... so, where can you combine resources and activities, and ... These are just a few of the ...
(Date:7/25/2014)... , July 25, 2014 /PRNewswire-iReach/ -- ScriptPro, of ... of Powers Lake, Wisconsin , ... a distribution and co-marketing agreement allowing ScriptPro to ... throughout the United States . ... management and workflow systems to retail and ambulatory ...
(Date:7/25/2014)... , July 25, 2014  The Chemistry, Food ... Ministry of Health approved the introduction of Telaprevir ... the cure rate from Hepatitis C, and it ... 1 virus. Telaprevir is available in ... Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
Breaking Medicine Technology:Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3
... Filtrona Porous Technologies, a custom developer and manufacturer ... to absorb, retain, transfer, filter or release fluids ... polyurethane foams and bonded fibers at the MEDICA ... 17 to 19 November 2010. ...
... Chimerix, Inc., a biopharmaceutical company advancing orally-available antiviral therapeutics ... Moch, President and Chief Executive Officer, will present at ... Wednesday, November 17, 2010, 10:30 a.m. ET, at the ... Mr. Moch will give an update on the company,s ...
Cached Medicine Technology:Chimerix to Present at the Lazard Capital Markets 7th Annual Healthcare Conference 2
(Date:7/27/2014)... analysis of hepatitis E virus (HEV) transmission by blood ... England have HEV in their plasma. The findings, published ... HEV-containing blood components (eg, red cells, platelets, and fresh ... in England. , The study retrospectively screened 225 ... between Oct, 2012 and Sept, 2013 for HEV RNA. ...
(Date:7/27/2014)... 2014 The report, “Glass Fiber ... By Raw Material, By Manufacturing Process, By Application ... By Geography – Global Trends & Forecast to ... market with an analysis and forecast by value ... and 107 figures spread through 347 slides and ...
(Date:7/27/2014)... medication to treat asthma and pneumonia can become ineffective. , ... drugs widely used to treat lung diseases work with the ... is caused by an infection, affects around 1 in 1000 ... children, the elderly, smokers and those with an underlying health ... UK are affected by asthma and the NHS spends around ...
(Date:7/27/2014)... Over the past five years, the ... well, thanks to many consumers valuing the taste and ... Coffee Association of Canada's Canadian Coffee Drinking Study in ... coffee per day. “This trend, coupled with many studies ... drinking tea on a daily basis, has stimulated consumer ...
(Date:7/27/2014)... 27, 2014 The report, “Oil Filter ... LCVs & HCVs), Market Type (OE & Aftermarket), Filter ... & Geography - Industry Trends & Forecast to 2018”, ... filters market with analysis and forecasting of the global ... is estimated to reach a revenue of $6.1 billion ...
Breaking Medicine News(10 mins):Health News:The Lancet: 1 in 3000 blood donors in England infected with hepatitis E 2Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 2Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 3Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 4Health News:Drugs used to treat lung disease work with the body clock 2Health News:Coffee and Tea Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Coffee and Tea Production in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 2Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 3Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 5
... U.S. households where English is not the primary language ... Medical Center researcher has found. , In a study ... Dr. Glenn Flores, professor of pediatrics at UT Southwestern ... of Children,s Health to examine whether disparities exist for ...
... BEDFORD, Mass., June 10 Insulet Corporation,(the "Company") (Nasdaq: ... a private,offering of $75 million in aggregate principal amount ... qualified institutional buyers in,reliance on Rule 144A under the ... the initial purchasers an option to purchase up to ...
... cardiac,arrest is a leading cause of death in ... it is imperative that every school develop an,emergency ... need to respond,effectively to children and adults who ... CPR and use an automated external defibrillator,(AED) are ...
... ,Best of Healthcare Furniture, ... Category for Third Straight ... by,Steelcase won the Gold Award in the Healthcare Furniture ... state-of-the-art product,design, technological innovation and environmental sustainability., (Photo: ...
... to kill cancer cells offer a promising strategy for ... body,s natural defenses often eliminate the viruses before they ... study by researchers at the Ohio State University Comprehensive ... improve this therapy for brain cancer patients. , The ...
... Snowe,(R-ME), member of the Senate Finance Committee, has ... pharmacy-related provisions to provide,prompt payment of Medicare Part ... Medicaid reimbursement cuts for generic prescription,drugs. In response, ... in,Camden, ME and a member of the National ...
Cached Medicine News:Health News:Children in non-English-speaking households face many health disparities, researcher concludes 2Health News:Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes 2Health News:Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes 3Health News:Statement of Robert O'Connor, M.D., M.P.H. Chair, American Heart Association, Emergency Cardiovascular Committee, on U.S. House of Representatives Passage of the Josh Miller HEARTS Act 2Health News:Three-peat: Nurture(R) Strikes Gold Again at NeoCon 2Health News:Cancer-killing viruses influence tumor blood-vessel growth 2Health News:Maine Community Pharmacy Owner Thanks Sen. Snowe for Supporting Inclusion of Common-Sense Reimbursement Provisions in Medicare Bill 2
... Shoulder Instrument Systems offer the ... and mini-open shoulder repairs, such ... repair. Smith & Nephew shoulder ... facilitate an easier and more ...
... Mini-Open Rotator Cuff Repair System facilitates ... time, incision size and the likelihood ... rotator cuff repair systems and implants. ... of matched cortical gauge punches, circular ...
Portal accessory instrument set. Set also includes a package of 8 mm Guide Wires (.15 cm x 38 cm), and Sterilization Tray....
... The Blitz Suture Retriever is for arthroscopic and ... of design eliminates complicated procedural steps. It ... of suture material and in conjunction with,anchors or ... A small, curved needle tip permits the placement ...
Medicine Products: